"Tubulin Modulators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES.
| Descriptor ID |
D050257
|
| MeSH Number(s) |
D27.505.519.593.249.500
|
| Concept/Terms |
Tubulin Modulators- Tubulin Modulators
- Modulators, Tubulin
- Microtubule Modulators
- Modulators, Microtubule
Tubulin Promoters- Tubulin Promoters
- Promoters, Tubulin
- Tubulin Polymerization Promoters
- Polymerization Promoters, Tubulin
- Promoters, Tubulin Polymerization
Tubulin Inhibitors- Tubulin Inhibitors
- Inhibitors, Tubulin
- Tubulin Polymerization Inhibitors
- Inhibitors, Tubulin Polymerization
- Polymerization Inhibitors, Tubulin
|
Below are MeSH descriptors whose meaning is more general than "Tubulin Modulators".
Below are MeSH descriptors whose meaning is more specific than "Tubulin Modulators".
This graph shows the total number of publications written about "Tubulin Modulators" by people in this website by year, and whether "Tubulin Modulators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 3 | 7 |
| 2018 | 3 | 0 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 1 | 4 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Tubulin Modulators" by people in Profiles.
-
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatol Clin (Engl Ed). 2021 Aug-Sep; 17(7):371-375.
-
Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis. Eur J Clin Invest. 2021 Sep; 51(9):e13645.
-
Alpha-defensins: risk factor for thrombosis in COVID-19 infection. Br J Haematol. 2021 07; 194(1):44-52.
-
Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Clin Exp Pharmacol Physiol. 2021 06; 48(6):823-830.
-
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med. 2021 03; 178:106322.
-
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int. 2020 09; 40(9):1423-1431.
-
Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):255.
-
May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection? Cell Biol Int. 2020 09; 44(9):1770-1772.
-
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e2013136.
-
Colchicine may not be effective in COVID-19 infection; it may even be harmful? Clin Rheumatol. 2020 07; 39(7):2101-2102.